TABLE 1.
Characteristic | Value |
||||
---|---|---|---|---|---|
Group 1 (booster ZVL recipients ≥70 yr old) | Group 2 (first-time ZVL recipients ≥70 yr old) | Group 3 (first-time ZVL recipients 60–69 yr old) | Group 4 (first-time ZVL recipients 50–59 yr old) | Total | |
No. of participants/group | 201 | 199 | 100 | 100 | 600 |
No. (%) of patients of gender | |||||
Male | 94 (46.8) | 105 (52.8) | 35 (35.0) | 23 (23.0) | 257 (42.8) |
Female | 107 (53.2) | 94 (52.8) | 65 (65.0) | 77 (77.0) | 343 (57.2) |
Mean age (yr) (SD) | 77.1 (4.5) | 76.3 (5.1) | 64.1 (3.1) | 55.5 (2.8) | 71.1 |
Median age (yr) | 76.0 | 75.0 | 63.0 | 56.0 | 73.0 |
No. (%) of patients of race | |||||
Native American or Asian | 0 (0.0) | 4 (2.0) | 1 (1.0) | 0 (0.0) | 2 (0.3) |
Black | 1 (0.5) | 5 (2.5) | 8 (8.0) | 6 (6.0) | 20 (3.3) |
White | 200 (99.5) | 188 (94.5) | 90 (90.0) | 93 (93.0) | 571 (95.2) |
No. (%) of patients of ethnicity | |||||
Hispanic | 2 (1.0) | 2 (1.0) | 0 (0.0) | 4 (4.0) | 8 (1.3) |
Not Hispanic | 198 (98.5) | 196 (98.5) | 100 (100.0) | 96 (96.0) | 590 (98.3) |
Abbreviations: ZVL, live zoster vaccine; SD, standard deviation.